Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 942, pseudogene (RNU6-942P)** is a transcribed but non-functional genomic sequence classified as a pseudogene of the U6 small nuclear RNA (snRNA) gene. The canonical, functional U6 snRNA is a highly conserved component of the spliceosome complex, crucial for pre-mRNA splicing in eukaryotes[3][1]. In the human genome, numerous copies of U6 or U6-derived pseudogenes exist, which generally do not code for functional snRNAs[3]. RNU6-942P is one such pseudogene; it is non-coding and not known to participate in canonical spliceosomal activity or to have direct biological, disease, or drug interaction roles[5][6]. There is no known evidence for it being a therapeutic target, biomarker, or mediator of pharmacological effect. Some pseudogenes might play regulatory roles (for instance as competitive endogenous RNAs), but for RNU6-942P there is currently no specific functional, disease, or mechanistic information[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 942, pseudogene (RNU6-942P).